Document Type

Article

Abstract

Iron is an essential nutrient that facilitates cell proliferation and growth. However, iron also has the capacity to engage in redox cycling and free radical formation. Therefore, iron can contribute to both tumour initiation and tumour growth; recent work has also shown that iron has a role in the tumour microenvironment and in metastasis. Pathways of iron acquisition, efflux, storage and regulation are all perturbed in cancer, suggesting that reprogramming of iron metabolism is a central aspect of tumour cell survival. Signalling through hypoxia-inducible factor (HIF) and WNT pathways may contribute to altered iron metabolism in cancer. Targeting iron metabolic pathways may provide new tools for cancer prognosis and therapy.

Comments

Nat Rev Cancer. Author manuscript; available in PMC May 28, 2014. Published in final edited form as: Nat Rev Cancer. May 2013; 13(5): 342–355. Published online Apr 18, 2013. doi: 10.1038/nrc3495 PMCID: PMC4036554 NIHMSID: NIHMS588334

Share

COinS